Lexagene Holdings Inc LXXGQ

Healthcare Medical Devices

Lexagene Holdings Inc. is a molecular diagnostics company engaged in researching, developing and commercializing automated genetic analyzer devices in clinical and life science industries. The Company is focused on developing molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The Company's MiQLab System is an automated, open-access molecular diagnostic system for pathogen detection, allowing users to test for multiple pathogens onsite, returning results in approximately 2 hours. Its MiQLab System is an automated, multiplexing polymerase chain reaction (PCR)-based system designed for syndromic testing in human clinical diagnostics and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets.

GREY:LXXGQ - Post by User

Lexagene Holdings Inc > I've got a sneaky feeling

<< Previous

Bullboard Posts

Next >>

Comment by Investor62on Dec 07, 2020 4:24am

81 Views

Post# 32047830

RE:RE:RE:RE:RE:RE: I've got a sneaky feeling

I don’t think it is Moderna as in the press release, they wrote:
“from a multinational biotechnology company that generates billions in annual revenue”
Moderna will have in 2020 Sales of $395M and in 2021 5B – in 2020 they are still losing money while in 2021 they expect $2,5B. I would more tend to Pfizer (PFN) or Merck (MRK), Eli Lilly (LLY) or Bristol-Meyers (BMY) – they all have billions in annual revenue

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide